Analysts See Indian Drug Makers In Good Position For Near-Term Growth
This article was originally published in PharmAsia News
Executive Summary
India’s drug makers are in a good position for future growth as events combine to spur sales, particularly for Cipla, Dr. Reddy’s Laboratories, Lupin and Ranbaxy Laboratories, a research report says.